Trials / Unknown
UnknownNCT03298347
Caffeine for Preterm Infants With Apnea of Prematurity(AOP)
Caffeine for Preterm Infants With Apnea of Prematurity(AOP): a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
- Sex
- All
- Age
- 1 Minute – 1 Month
- Healthy volunteers
- Not accepted
Summary
Nowadays,caffein is commonly used for AOP, and it reduces the intubation rate in preterm infants. However, intubation is needed in about 20%-50% of partial neonates. How to reduce the intubation rate effectively is a challenge for neonatologists.
Detailed description
Less evidences about more dose of caffein used in preterm infants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 80mg/kg of caffeine | 80mg/kg of caffeine is given to treat AOP |
| DRUG | 20mg/kg of caffeine | 20mg/kg of caffeine is given to treat AOP |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
- First posted
- 2017-10-02
- Last updated
- 2017-10-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03298347. Inclusion in this directory is not an endorsement.